Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-30

Clinical Trial Update: DIalysis Symptom COntrol-Pruritus Outcome Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing dialysis symptom control for pruritus in patients with end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Manitoba | Conditions: End Stage Renal Disease, Pruritus | Phase 3 | Status: COMPLETED